AAG
CC icon

Accordant Advisory Group’s Chemours CC Stock Holding History

Accordant Advisory Group’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-65
Closed -$1.32K – 143
2024
Q3 		$1.32K Buy
65
+45
+225% +$920 ﹤0.01% 138
2024
Q2 		$451 Hold
20
– – ﹤0.01% 147
2024
Q1 		$525 Buy
+20
New +$570 ﹤0.01% 196

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Accordant Advisory Group's CC Position: Q4 2024 in Review

Accordant Advisory Group sold out of Chemours (CC) in Q4 2024, closing a stake of 65 shares — an estimated $1.32K sold.

Accordant Advisory Group first reported a position in CC in Q1 2024 and held it in 3 quarters. The position peaked at $1.32K in Q3 2024. 442 funds tracked by Wall St. Rank hold CC as of Q4 2024.

  • Accordant Advisory Group reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
  • Accordant Advisory Group sold 65 Chemours shares in Q4 2024, an estimated $1.32K.
  • Accordant Advisory Group first reported a position in Chemours in Q1 2024 and held it in 3 quarters.
  • Accordant Advisory Group's Chemours position peaked at $1.32K in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on Accordant Advisory Group's 13F filing for Q4 2024, filed 23 Jan 2025.